- $227.23m
- $236.62m
- $208.67m
- 52
- 66
- 79
- 72
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 189 | 209 | 227 | 233 | 167 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 190 | 188 | 242 | 239 | 167 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 48.7 | 102 | 147 | 84.7 | -32.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 40.7 | 80 | 115 | 66.5 | -27.5 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 17.5 | 80 | 115 | 66.5 | -27.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 17.5 | 80 | 115 | 66.5 | -27.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.43 | 3.07 | 5.46 | 3.49 | -0.045 |
Dividends per Share |